Opus Genetics (IRD) Cash from Investing Activities Growth (3y) (2013 - 2024)
Opus Genetics (IRD) Cash from Investing Activities Growth (3y) (2013 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
116.52% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
38.24% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Opus Genetics |
355.39 Mn |
295.43 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
141.59% |
| Dec 31, 2021 |
-27.03% |
| Dec 31, 2020 |
29.58% |
| Dec 31, 2019 |
-26.54% |
| Sep 30, 2019 |
52.89% |
| Jun 30, 2019 |
6.52% |
| Mar 31, 2019 |
-97.40% |
| Dec 31, 2018 |
35.13% |
| Sep 30, 2018 |
-19.25% |
| Jun 30, 2018 |
7.22% |
| Mar 31, 2018 |
-10.89% |
| Dec 31, 2017 |
-11.10% |
| Sep 30, 2017 |
28.99% |
| Jun 30, 2017 |
-413.85% |
| Mar 31, 2017 |
190.99% |
| Dec 31, 2016 |
147.31% |
| Sep 30, 2016 |
-407.07% |
| Jun 30, 2016 |
85.62% |
| Mar 31, 2016 |
-97.63% |
| Dec 31, 2015 |
-69.74% |
